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ABSTRACT
Introduction: Current literature suggests that tracheostomy has no impact on survival 
in unselected intensive care unit (ICU) patients, and that it actually transfers mortality 
from ICU to the ward.
Methods: Data from 71 adult subjects who underwent tracheostomy as part of their 
ICU management and were subsequently transferred to the ward were obtained 
retrospectively.
Results: During 2015, 104 subjects received tracheostomy. Thirty-two died during 
their initial ICU admission (30.4%) and were excluded from analysis. Of the remaining 
73 individuals, 28 died (38.3%) in hospital. Most common diagnoses were sepsis 
(33.8%) and neurological emergencies (23.9%). Life-sustaining treatments were 
withheld or withdrawn in 25 decedents. Seven subjects died in later hospitalizations 
at our institution over the period recorded.
Conclusions: Tracheostomy may represent a burden after ICU discharge, involving 
high resource use and low survival rate. Efforts should be made to recognize patients 
who might clearly benefit from this technique to avoid unwanted prolonged mechanical 
ventilation.
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Placement of tracheostomy in the intensive care unit (ICU) is commonly 
believed to allow a more secure and manageable airway and to facilitate 
weaning from mechanical ventilation. Prolonged mechanical ventilation 
accounts for over half of tracheostomy indications1. Early tracheostomy is 
often undertaken due to severe neurological conditions, which are traditionally 
excluded from clinical trials2.
Current evidence shows that early tracheostomy does not improve any 
patient-centered outcome and increases the number of procedures being 
performed3,4. There is no specific duration of mechanical ventilation that demands 
tracheostomy. Some investigators suggest that although tracheostomy speeds 
ICU discharge and thus increases ICU survival, many of these patients die in 
the ward, resulting in a null effect on overall in-hospital mortality5.
Patients requiring prolonged mechanical ventilation have a 1-year mortality 
rate of 50-60%6. However, at the time of tracheostomy for failure to liberate 
from the ventilator in the ICU, most patients and families lack a meaningful 
understanding of what lies ahead7. Perhaps for patients suffering from 
neurological injuries, more important is their potential for meaningful recovery, 
otherwise it is quite unlikely they would benefit from tracheostomy regardless 
of timing. Many patients and families are also unaware of alternatives to 
indefinite continuation of intensive care therapies, including limitation of life 
support while preserving the patient’s comfort8-10.
The purpose of this investigation was to describe main characteristics 
and outcomes of tracheostomized patients discharged from ICU to the ward 
in a public hospital.
http://seer.ufrgs.br/hcpaClin Biomed Res 2019;39(1) 86
Antônio, Leivas
METHODS
We conducted a retrospective observational 
investigation of data collected from electronic medical 
records. We included all adult subjects who underwent 
tracheostomy as part of their ICU management 
and were subsequently transferred to the ward in 
2015 – date of ICU discharge was used as inclusion 
criterion, even if tracheostomy had been performed 
before that. The setting was four adult medical-surgical 
ICUs (44 beds) at a tertiary care public hospital 
in southern Brazil. Individuals who died in ICU at 
first admission were excluded. Demographic data, 
diagnoses on admission, comorbidities, duration of 
mechanical ventilation, ICU length of stay, end-of-life 
decisions and mortality were retrieved.
Results were expressed as mean and standard 
deviation, median and interquartile range, and 
proportions, as appropriate. The normal distribution 
of the various parameters was investigated observing 
the distribution of data and the Shapiro-Wilk test. 
We  used the Fisher exact test to compare proportions 
and the Mann-Whitney U test or t-test to compare 
continuous variables according to their distribution. 
A post hoc analysis was performed comparing living 
and deceased individuals by the end of 2015 according 
to their clinical characteristics. A p-value < 0.05 was 
taken to be statistically significant. Statistical analysis 
was performed with STATA, version 13.0.
RESULTS
From October 2014 to December 2015, 105 of 
a total of 1327 critically ill patients received surgical 
tracheostomy. Thirty-two died during their initial ICU 
admission (30.4%) and therefore were excluded from 
analysis. The mean age of 73 included individuals 
was 56.9 ± 17.7 years, 52.1% were male and 
mean APACHE  II score was 21.6 ± 6.8 points. 
Chronic neurologic disorders and cancer were main 
comorbidities (21.1% and 14%, respectively). Most 
common admission diagnoses were sepsis (33.8%) 
and neurological emergencies (stroke, intracerebral 
hemorrhage, meningitis) (23.9%). Length of ICU stay 
was 30.7 ± 17 days and total duration of mechanical 
ventilation was 23 (13-29) days. Patients spent a 
median of 15 (11-19) days on mechanical ventilation 
before undergoing tracheostomy. There were no reports 
of severe adverse events related to tracheostomy.
Four individuals were readmitted to the ICU within 
48 hours of ICU discharge. Twenty-eight eventually 
died in hospital. Life-sustaining treatments were 
withheld or withdrawn in 30 tracheostomized patients. 
Seven subjects died in later hospitalizations at our 
institution over the period recorded. In-hospital 
mortality for individuals with at least one admission 
to ICU during 2015 was 48.1%, whereas for this 
cohort of 73 subjects it was 57.7%.
Table 1 shows the main characteristics of the 
cohort according to survival status by the end of 
the study period.
DISCUSSION
We presented a retrospective review of subjects 
receiving surgical tracheostomy during ICU care in 
our institution during a 1-year period. Despite the 
short period of observation and lack of comparison 
to other populations, we perceived that it might be 
a misunderstanding surrounding prognosis after 
tracheostomy decision. Before initiating another 
invasive procedure, a consideration of the patient’s 
prognosis and burden of discomfort should be 
undertaken relative to their values and wishes for 
prolonged invasive care.
Unlike a previous trial11, only the motor component of 
the Glasgow coma scale at ICU discharge significantly 
differed between survivors and decedents in 2015, 
yet of no clinical relevance. Life-threatening adverse 
events directly related to placement or maintenance 
of tracheostomy were not reported. Early indication 
for the procedure was not an issue in our research.
One explanation for the growth of prolonged 
mechanical ventilation provision despite poor patient 
outcomes6 is that the decision to pursue this level of 
care may be based on inadequate surrogate-physician 
interactions, unrealistic expectations and poor 
communication7. A survey12 reported physicians’ 
general discomfort with withholding or withdrawing 
life support in the face of prognostic uncertainty. 
Intensivists might hesitate to communicate when 
the problems, treatment options, and prognoses are 
not well defined. Furthermore, surrogates often lack 
knowledge of patients’ wishes for life support and 
have poor comprehension of their medical problems13. 
In a prospective observational study10, only 21% of 
surrogates reported physicians had discussed potential 
consequences of tracheostomy placement including 
procedural risks, impact on discharge disposition, 
need for long-term ventilator support, and feeding 
route. Families often misinterpret the recommendation 
of tracheostomy as a positive event and a sign of 
hope for full recovery14. Less educated subjects are 
at higher risk of receiving less information about the 
potential outcomes of treatment8. In Brazil, physicians 
from 11 university-affiliated ICUs said they would do 
differently in 44% of cases from what they believed 
was best for the patient, but legal fears followed by 
team and societal opinion still impact their end-of-life 
decisions15. Therefore, content of physician-surrogate 
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communication is often inadequate for fully shared 
decision-making.
As expected, tracheostomy was a marker of higher 
mortality. What amount of such poor outcomes could be 
anticipated and honestly disclosure to decision-makers? 
Similar to another prospective study9, despite poor 
outcomes, limitation of disproportionate care occurred 
late in the present cohort. Our findings indicate a 
serious need to improve end-of-life care planning. 
The default strategy to prescribe tracheostomy and 
postpone discontinuation of life-prolonging therapies 
on a large proportion of neurologic injured and 
cancer patients implies an urge for comprehensive 
redefinition of goals.
Limitations of our investigation are worth noting. 
The association between clinical characteristics and 
outcomes is merely hypothesis-generated as it was 
not an endpoint defined a priori. We were unable to 
make any further inferences regarding end-of-life 
decisions owing to serious lack of information on 
medical records regarding family meetings and 
patient and proxy preferences. We did not interview 
ICU physicians to document their personal views 
regarding long-term prognosis for chronic critical 
illness. Data regarding decannulation, quality of life 
and chronic disability of survivors are also absent. 
There is no outreach team at the medical center 
that could assist tracheostomized patients after 
ICU discharge, and this deserves additional caution 
regarding generalizability.
A recently published mortality prediction model 
for prolonged mechanical ventilation may inform 
the discussion between surrogates and clinicians 
and improve prognostic accuracy16. We must be 
prepared to discuss the limitations of technology to 
cure and provide comfort care to patients and families. 
Tracheostomy and other potentially disproportionate 
interventions should never be driven by default.
CONCLUSION
Tracheostomy may represent a burden after 
ICU discharge, involving high resource use and low 
survival rate. Indication for tracheostomy should be 
cautious, and efforts should be made to recognize 
patients who might clearly benefit from this technique 
to avoid unnecessary and unwanted prolonged 
mechanical ventilation. All the decisions we make 
in the ICU have an important impact on future care 
needs. Even if earlier communication about expected 
outcomes does not change decision-making at the 
Table 1: Characteristics of study cohort according to survival status.
Tracheostomized patients after ICU discharge (n = 71)* Living in 2015 (n= 36)* Deceased (n= 35) p
Age (years) 52 (41-64) 62.5 (50-71.7) 0.04
Female gender 36 35 0.64
Time to tracheostomy (days) 15 (12-19) 12.5 (8.7-16.7) 0.59
Total MV duration (days) 26 (16-33) 19.5 (12.2-28) 0.33
APACHE II (score) 20 (15.5-25.5) 22 (21-25) 0.048
SOFA (score) 7 (4-11) 6 (3.2-9) 0.76
Length of ICU stay (days) 33 (20-41) 21 (15.2-32.7) 0.13
Length of hospital stay (days) 69 (51-84) 57 (34-91) 0.07
VAP diagnosis 19 17 0.81
RRT at ICU discharge 8 9 0.79
Copious secretions at ICU discharge 12 17 0.26
Need of intermittent positive pressure ventilation at ICU 
discharge
8 5 0.54
Limitation of therapeutic efforts 4 26 <0.001
Motor GCS at ICU discharge 6 (5-6) 5.5 (1-6) 0.008
Admission due to stroke, SAH or meningitis 3 10 0.03
BMI > 30 (kg/m2) 5 5 1
Prior neurological sequelae 3 9 0.4
COPD 4 4 0.5
Heart failure 3 2 1
Neoplasia 2 8 0.046
*Excluding 2 patients who were still hospitalized by the time we had concluded data collection. Data are presented as median (interquartile 
range), mean ± SD or n (%). ICU = intensive care unit; MV = mechanical ventilation; APACHE II = Acute Physiology and Chronic Health 
Evaluation II; SOFA = Sequential Organ Failure Assessment; VAP = ventilator-associated pneumonia; RRT = renal replacement therapy; 
GCS = Glasgow coma scale; SAH = subarachnoid hemorrhage; BMI = body mass index; COPD = chronic obstructive pulmonary disease.
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outset, such communication may help prepare patients 
and families for events, discussions, and decisions 
they are likely to face later.
Knowledge of characteristics and outcomes may 
assist in identifying interventions to reduce the need 
for tracheostomy or improve outcomes. In this sense, 
larger and prospective cohorts are needed.
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